Latest / PETRI DISH PERSPECTIVES
Episode 50: Exact Sciences
Send us Fan Mail
In this episode of Petri Dish Perspectives, we’re dissecting the "Phoenix of Biotech." On March 23, 2026, the era of Exact Sciences as an independent company officially ended with its massive $23 billion acquisition by Abbott Laboratories. But the road to this exit wasn't paved with easy wins, it was forged in the wreckage of a "zombie" penny stock that almost didn't survive 2008.
We take you through the high-stakes gamble of the DeeP-C trial, the behavioral economics behind the "Little Blue Box," and the strategic brilliance of the Genomic Health merger. We explore how Kevin…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.